The United States Patent and Trademark Office (USPTO) has granted patent US12582608B2 to Nortiva Bio, Inc. The patent, titled "Coatings for gastric residence dosage forms," describes enrobed gastric residence dosage forms that include a gastric residence system in a folded configuration and a coating. The coating is composed of water, a plasticizer, a gelling agent, and/or a polymer. This patent is related to the development of novel drug delivery systems designed to release medication in the stomach.

This is a patent grant, which is a form of intellectual property protection rather than a regulatory mandate. It does not impose new compliance obligations on regulated entities. However, it signifies innovation in pharmaceutical formulation and may influence future product development strategies for companies operating in the drug manufacturing and pharmaceutical sectors. Compliance officers should note this as a development in the industry landscape.